Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease
Clinical trial NCT00191009 · COMPLETED
Trial details
- NCT number
- NCT00191009
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.